مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

119
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

76
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Evaluation of the Efficacy of Lentiviral Vectors in Gene Therapy of Beta-thalassemia Patients: A Systematic Review

Pages

  11243-11250

Abstract

 Background: Beta thalassemia is a genetic blood abnormality identified through mutations, which reduce the synthesis of the ß-globin chain. Gene therapy through Lentiviral Vectors have cured many of genetic disorders. The purpose of this study was to investigate the efficacy of Lentiviral Vectors in treatment of ß-thalassemia as a novel approach for sustained treatment and prevention of recurrent blood transfusion that has many adverse effects on the patients. Materials and Methods: In this systematic review, a systematic search of online databases (Web of Science, Scopus, and Medline) with no language restriction between 2012 and 2020 using the combination related keywords of Mesh included (Thalassemia OR Beta thalassemia OR β _thalassemia OR BTM) AND (Lentivirus) AND (Genetic therapy OR Gene therapy). All valuable data was allocated, and two independent researchers considered all articles. Results: Finally, 20 articles that met the criteria were selected. Articles were quantitative (n=16), and qualitative (n=4), their year of publication varied from 2012 to 2020. Results showed that the main outcome of the desired survey was therapeutic treatments for thalassemia worldwide. While highly compatible donors for allogeneic bone marrow transplantation are accessible to less than 30% of all patients, Gene therapy has emerged as a holistic and practical approach for the remaining 70%. Conclusion: Nowadays, with the development of Gene therapy, there is hope for a cure for genetic diseases. The successes of Gene therapy techniques can bring laboratory methods of Gene therapy a step closer to clinical and general use as a common treatment for genetic defects.

Cites

  • No record.
  • References

    Cite

    APA: Copy

    Dorgaleleh, Saeed, Barahouie, Ahmad, Dastaviz, Farzad, Ghodsalavi, Zahrasadat, & OLADNABI, MORTEZA. (2020). Evaluation of the Efficacy of Lentiviral Vectors in Gene Therapy of Beta-thalassemia Patients: A Systematic Review. INTERNATIONAL JOURNAL OF PEDIATRICS, 8(5 (77)), 11243-11250. SID. https://sid.ir/paper/785105/en

    Vancouver: Copy

    Dorgaleleh Saeed, Barahouie Ahmad, Dastaviz Farzad, Ghodsalavi Zahrasadat, OLADNABI MORTEZA. Evaluation of the Efficacy of Lentiviral Vectors in Gene Therapy of Beta-thalassemia Patients: A Systematic Review. INTERNATIONAL JOURNAL OF PEDIATRICS[Internet]. 2020;8(5 (77)):11243-11250. Available from: https://sid.ir/paper/785105/en

    IEEE: Copy

    Saeed Dorgaleleh, Ahmad Barahouie, Farzad Dastaviz, Zahrasadat Ghodsalavi, and MORTEZA OLADNABI, “Evaluation of the Efficacy of Lentiviral Vectors in Gene Therapy of Beta-thalassemia Patients: A Systematic Review,” INTERNATIONAL JOURNAL OF PEDIATRICS, vol. 8, no. 5 (77), pp. 11243–11250, 2020, [Online]. Available: https://sid.ir/paper/785105/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button